Improving heart failure care for Medicare patients
Evaluating Policies to Improve Heart Failure Outcomes in Medicare
['FUNDING_OTHER'] · BETH ISRAEL DEACONESS MEDICAL CENTER · NIH-10865455
This study looks at how new Medicare policies can improve care for the 6.5 million Americans with heart failure, especially those on Medicare, by comparing their experiences with different Medicare plans and seeing how recent changes might help lower their medication costs.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BETH ISRAEL DEACONESS MEDICAL CENTER (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10865455 on ClinicalTrials.gov |
What this research studies
This research investigates how recent Medicare policy changes can enhance care for the 6.5 million Americans with heart failure, particularly those enrolled in Medicare. It compares the experiences of patients in Medicare Advantage plans versus traditional fee-for-service Medicare, focusing on access to care, affordability, and health outcomes. The study also examines the impact of the Inflation Reduction Act, which aims to lower out-of-pocket drug costs for Medicare beneficiaries. By analyzing these factors, the research seeks to identify effective strategies to improve heart failure management.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicare beneficiaries diagnosed with heart failure.
Not a fit: Patients who are not enrolled in Medicare or do not have a diagnosis of heart failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and better access to care for heart failure patients on Medicare.
How similar studies have performed: Previous research has shown that policy changes can significantly impact healthcare access and outcomes, suggesting potential success for this approach.
Where this research is happening
BOSTON, UNITED STATES
- BETH ISRAEL DEACONESS MEDICAL CENTER — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OSERAN, ANDREW SEYMOUR — BETH ISRAEL DEACONESS MEDICAL CENTER
- Study coordinator: OSERAN, ANDREW SEYMOUR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.